Tag: AVT02

Alvotech’s BLA for AVT02 receives a comprehensive response letter from the US FDA.

April 15, 2023
The US Food and Drug Administration (FDA) has responded completely to Alvotech’s Biologics Licence Application (BLA) for AVT02,…

Registration Form


This will close in 0 seconds

WhatsApp Telegram